These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8707107)

  • 1. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.
    Holloway RH; Dent J; Narielvala F; Mackinnon AM
    Gut; 1996 May; 38(5):649-54. PubMed ID: 8707107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.
    Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of omeprazole in reflux oesophagitis.
    Dent J; Hetzel DJ; MacKinnon MA; Reed WD; Narielvala FM
    Scand J Gastroenterol Suppl; 1989; 166():76-82; discussion 94. PubMed ID: 2690334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.
    Havelund T; Aalykke C; Rasmussen L
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):509-14. PubMed ID: 9187886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):279-87. PubMed ID: 11950384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oesophageal motility and gastro-oesophageal reflux before and after healing of reflux oesophagitis. A study using 24 hour ambulatory pH and pressure monitoring.
    Timmer R; Breumelhof R; Nadorp JH; Smout AJ
    Gut; 1994 Nov; 35(11):1519-22. PubMed ID: 7828965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
    Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
    Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
    Katz PO; Ginsberg GG; Hoyle PE; Sostek MB; Monyak JT; Silberg DG
    Aliment Pharmacol Ther; 2007 Mar; 25(5):617-28. PubMed ID: 17305763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
    Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
    Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.
    Laursen LS; Havelund T; Bondesen S; Hansen J; Sanchez G; Sebelin E; Fenger C; Lauritsen K
    Scand J Gastroenterol; 1995 Sep; 30(9):839-46. PubMed ID: 8578181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.
    Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C
    Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of treating reflux oesophagitis with omeprazole on quality of life.
    McDougall NI; Collins JS; McFarland RJ; Watson RG; Love AH
    Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):459-64. PubMed ID: 9855059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
    Orel R; Brecelj J; Homan M; Heuschkel R
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.